Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Dr. C H Weaver MD
July 28, 2026
FDA Approves the First Regulatory T-Cell Therapy to Improve Stem Cell Transplant Outcomes for Blood Cancers
Dr. C H Weaver MD
July 25, 2026
Can a Blood Test Tell If Rectal Cancer Treatment Really Worked?
Dr. C H Weaver MD
July 22, 2026
A New Treatment Option Approved for Some Advanced Breast Cancers: What Patients Should Know About REVTORPYK
Dr. C H Weaver MD
July 13, 2026
A Blood Test May Help Personalize Treatment After Colorectal Cancer Surgery
Dr. C H Weaver MD
July 8, 2026
ASCO 2026: Exciting Advances in Breast Cancer Research
Dr. C H Weaver MD
July 8, 2026
Finding Calm Through Movement: New Study Shows Yoga May Help Cancer Survivors Sleep Better and Feel Less Anxious
Dr. C H Weaver MD
June 16, 2026
FDA Approves New Adjuvant Treatment Option for Patients at High Risk of Kidney Cancer Recurrence
Dr. C H Weaver MD
June 16, 2026
FDA Approves First Targeted Therapy for Certain Patients With Metastatic Prostate Cancer
Dr. C H Weaver MD
June 15, 2026
Ivonescimab Plus Chemotherapy Helps Patients With Advanced Squamous Lung Cancer Live Longer
Dr. C H Weaver MD
June 9, 2026
GLP-1 Use Linked to Lower Breast Cancer Incidence in One Study
Dr. C H Weaver MD
June 4, 2026
Blood Tests to Track Cancer: Understanding Your ctDNA and Liquid Biopsy Options
Dr. C H Weaver MD
June 1, 2026
FDA Grants Accelerated Approval to Sonrotoclax (Begalzi) for Relapsed or Refractory Mantle Cell Lymphoma
Dr. C H Weaver MD
1
2
3
…
382
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
